Format

Send to

Choose Destination
Crit Care Clin. 2013 Jul;29(3):547-62. doi: 10.1016/j.ccc.2013.03.008.

Staphylococcus aureus bacteremia, risk factors, complications, and management.

Author information

1
Section of Infectious Diseases, Department of Internal Medicine and Medical Microbiology, University of Manitoba, 543-745 Bannatyne Ave, Basic Sciences Bldg, Manitoba R3E 0J9, Canada.

Abstract

Staphylococcus aureus and methicillin-resistant S aureus have emerged as the most important nosocomial pathogens. Traditional therapy may be sufficient in most but not all patients, in whom alternatives should be sought. The infection is often complicated with several sites of metastatic foci and is nosocomial frequently. New antibiotics to fight MRSA have been introduced and are equivalent or better than vancomycin.

KEYWORDS:

Antibiotics; HAP; Infection; Linezolid; MRSA; MSSA; Staphylococcus aureus; Treatment; VAP; Vancomycin

PMID:
23830653
DOI:
10.1016/j.ccc.2013.03.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center